Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial - PubMed
3 hours ago
- #AI diagnostics
- #smartphone screening
- #ocular malignancies
- A smartphone-based AI system, CaptureTumor, was developed for self-screening of ocular surface malignancies, achieving high diagnostic accuracy comparable to slitlamp-based methods.
- In a nonrandomized trial in China, the system reached over 256,000 individuals via media outreach; 614 completed self-screening, detecting 20 pathologically confirmed malignancies, with 95% being newly diagnosed.
- The platform demonstrated strong performance at the population level, with an AUC of 0.977, sensitivity of 89.3%, and specificity of 95.9%, offering a scalable and accessible strategy for early detection of rare ocular diseases.